Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ)

Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) — VMCI valuation read

Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) carries a VMCI composite of 49/100, 1 points below the Healthcare sector median of 50. Among mid-cap names, that gap places 002755.SZ in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The 002755.SZ insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads 002755.SZ trades at 24.0x earnings, 33% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 3.4x is the binding constraint on the bear case, the line to track on Beijing Aosaikang Pharmaceutical Co., Ltd.'s next 10-Q.

002755.SZ fell 1.6% over the trailing 7 days, with a -2.7% read on a 30-day basis.